Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2025 07:07 ET | Source: Research and Markets

Chronic Obstructive Pulmonary Disease Treatment Devices Market Insights, Competitive Landscape, and Market Forecast 2024-2032

Dublin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ...
May 19, 2025 11:17 ET | Source: Research and Markets

Chronic Obstructive Pulmonary Disease (COPD) Seven-Market Drug Forecast and Market Analysis Report 2023-2025 & 2025-2033

Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD): Seven-Market Drug Forecast and Market Analysis - Update (2025)" has been added to ...
October 11, 2024 06:35 ET | Source: Research and Markets

COPD Seven (US, France, Germany, Italy, Spain, UK, Japan) Drug Market Analysis & Forecasts 2024: Sales to Reach $30.8 Billion in 2033 - GSK, AstraZeneca, and Sanofi/Regeneron Compete for First Place

Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "COPD: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM (US,...
August 31, 2023 06:24 ET | Source: Research and Markets

Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements

Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
August 31, 2023 06:22 ET | Source: Research and Markets

Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements

Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
August 31, 2023 06:19 ET | Source: Research and Markets

Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements

Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
February 23, 2023 07:58 ET | Source: Research and Markets

Anti-Asthmatics And COPD Drugs Global Market Report 2023: A $117.36 Billion Market by 2027 Featuring Novartis, Merck, GSK, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer and Abbott

Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics And COPD Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.Major players in the...
May 04, 2022 08:03 ET | Source: Research and Markets

The Worldwide Asthma and COPD Drugs Industry is Expected to Reach $52 Billion by 2030

Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Asthma and COPD Drugs Market by Diseases and Medication Class (Combination Drugs, Inhaled Corticosteroids, Short Acting Beta Agonists, Long Acting Beta...
December 09, 2021 03:33 ET | Source: Research and Markets

Global Anti-Asthmatics and COPD Drugs Markets Report 2021: Top 10 in Sales are Ellipta, Symbicort, Spiriva, Advair, Nucala, Xolair, Ventolin, Pulmicort, Fasenra, Flovent

Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to...
May 21, 2021 05:13 ET | Source: Research and Markets

Global Anti-Asthmatics and COPD Drugs Market Report 2021 with Focus on COVID-19 Impacts - Major Players are Novartis AG, Merck & Co, GlaxoSmithKline, Boehringer Ingelheim and AstraZeneca

Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's...